These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31054882)

  • 1. Early neurochemical modifications of monoaminergic systems in the R6/1 mouse model of Huntington's disease.
    Puginier E; Bharatiya R; Chagraoui A; Manem J; Cho YH; Garret M; De Deurwaerdère P
    Neurochem Int; 2019 Sep; 128():186-195. PubMed ID: 31054882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlative analysis of dopaminergic and serotonergic metabolism across the brain to study monoaminergic function and interaction.
    Dellu-Hagedorn F; Fitoussi A; De Deurwaerdère P
    J Neurosci Methods; 2017 Mar; 280():54-63. PubMed ID: 28161298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Administration of Fipronil Heterogeneously Alters the Neurochemistry of Monoaminergic Systems in the Rat Brain.
    Bharatiya R; Chagraoui A; De Deurwaerdere S; Argiolas A; Melis MR; Sanna F; De Deurwaerdere P
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
    Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease.
    Hickey MA; Reynolds GP; Morton AJ
    J Neurochem; 2002 Apr; 81(1):46-59. PubMed ID: 12067237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexually dimorphic dopaminergic dysfunction in a transgenic mouse model of Huntington's disease.
    Renoir T; Argyropoulos A; Chevarin C; Lanfumey L; Hannan AJ
    Pharmacol Biochem Behav; 2014 Dec; 127():15-20. PubMed ID: 25316307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamines tissue content analysis reveals restricted and site-specific correlations in brain regions involved in cognition.
    Fitoussi A; Dellu-Hagedorn F; De Deurwaerdère P
    Neuroscience; 2013; 255():233-45. PubMed ID: 24120557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered dopamine and serotonin metabolism in motorically asymptomatic R6/2 mice.
    Mochel F; Durant B; Durr A; Schiffmann R
    PLoS One; 2011 Mar; 6(3):e18336. PubMed ID: 21483838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's disease.
    Kung VW; Hassam R; Morton AJ; Jones S
    Neuroscience; 2007 Jun; 146(4):1571-80. PubMed ID: 17478055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine.
    Petersén A; Hansson O; Puschban Z; Sapp E; Romero N; Castilho RF; Sulzer D; Rice M; DiFiglia M; Przedborski S; Brundin P
    Eur J Neurosci; 2001 Nov; 14(9):1425-35. PubMed ID: 11722604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington's disease: evidence for an overactive dopaminergic brain transmission.
    Garrett MC; Soares-da-Silva P
    J Neurochem; 1992 Jan; 58(1):101-6. PubMed ID: 1309230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.
    Date I; Felten DL; Felten SY
    Brain Res; 1990 Jun; 519(1-2):266-76. PubMed ID: 1975765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic ethanol consumption and aging on dopamine, serotonin, and metabolites.
    Woods JM; Druse MJ
    J Neurochem; 1996 May; 66(5):2168-78. PubMed ID: 8780050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington's Disease: A Targeted GC-MS/MS Sterol Analysis.
    Kreilaus F; Spiro AS; Hannan AJ; Garner B; Jenner AM
    J Huntingtons Dis; 2015; 4(4):305-18. PubMed ID: 26639223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice.
    Ooms M; Rietjens R; Rangarajan JR; Vunckx K; Valdeolivas S; Maes F; Himmelreich U; Fernandez-Ruiz J; Bormans G; Van Laere K; Casteels C
    Neurobiol Aging; 2014 Dec; 35(12):2858-2869. PubMed ID: 25018107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice.
    Petersén A; Puschban Z; Lotharius J; NicNiocaill B; Wiekop P; O'Connor WT; Brundin P
    Neurobiol Dis; 2002 Oct; 11(1):134-46. PubMed ID: 12460553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired dopamine release and uptake in R6/1 Huntington's disease model mice.
    Ortiz AN; Kurth BJ; Osterhaus GL; Johnson MA
    Neurosci Lett; 2011 Mar; 492(1):11-4. PubMed ID: 21256185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease.
    Johnson MA; Rajan V; Miller CE; Wightman RM
    J Neurochem; 2006 May; 97(3):737-46. PubMed ID: 16573654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional amines levels in the rat brain following intra-accumbens cholecystokinin and intraperitoneal amphetamine pre-treatment.
    Heidbreder C; Gewiss M; De Potter W; De Witte P
    Arch Int Physiol Biochim Biophys; 1992; 100(3):267-73. PubMed ID: 1382678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A whole brain longitudinal study in the YAC128 mouse model of Huntington's disease shows distinct trajectories of neurochemical, structural connectivity and volumetric changes.
    Petrella LI; Castelhano JM; Ribeiro M; Sereno JV; Gonçalves SI; Laço MN; Hayden MR; Rego AC; Castelo-Branco M
    Hum Mol Genet; 2018 Jun; 27(12):2125-2137. PubMed ID: 29668904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.